Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sino Biopharmaceutical Ltd (HK:1177)
HKEX:1177
Sino Biopharmaceutical (1177) Stock Price & Analysis
0 Followers
1177 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$2.29 - HK$4.06
Previous CloseHK$3.06
Volume29.38M
Average Volume (3M)54.72M
Market Cap
HK$57.29B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.0
Beta0.99
Next Earnings
Aug 29, 2024EPS Estimate
HK$0.09Next Dividend Ex-Date
Jun 11, 2024Dividend Yield2.61%
Share Statistics
EPS (TTM)0.14
Shares Outstanding18,801,217,230
10 Day Avg. Volume68,088,000
30 Day Avg. Volume54,719,685
Standard Deviation0.12
R-Squared0.08
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$5.31Price Target Upside73.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Options Prices
Currently, No data available
---
Ownership Overview
15.57% Insiders
2.40% Mutual Funds
4.47% Other Institutional Investors
77.57% Public Companies and
Individual Investors
1177 FAQ
What was Sino Biopharmaceutical Ltd’s price range in the past 12 months?
Sino Biopharmaceutical Ltd lowest stock price was HK$2.29 and its highest was HK$4.06 in the past 12 months.
What is Sino Biopharmaceutical Ltd’s market cap?
Currently, no data Available
When is Sino Biopharmaceutical Ltd’s upcoming earnings report date?
Sino Biopharmaceutical Ltd’s upcoming earnings report date is Aug 29, 2024 which is in 106 days.
How were Sino Biopharmaceutical Ltd’s earnings last quarter?
Sino Biopharmaceutical Ltd released its earnings results on Mar 28, 2024. The company reported HK$0.049 earnings per share for the quarter, missing the consensus estimate of HK$0.086 by -HK$0.038.
Is Sino Biopharmaceutical Ltd overvalued?
According to Wall Street analysts Sino Biopharmaceutical Ltd’s price is currently Undervalued.
Does Sino Biopharmaceutical Ltd pay dividends?
Sino Biopharmaceutical Ltd pays a Annually dividend of HK$0.03 which represents an annual dividend yield of 2.61%. See more information on Sino Biopharmaceutical Ltd dividends here
What is Sino Biopharmaceutical Ltd’s EPS estimate?
Sino Biopharmaceutical Ltd’s EPS estimate is HK$0.09.
How many shares outstanding does Sino Biopharmaceutical Ltd have?
Sino Biopharmaceutical Ltd has 18,801,217,000 shares outstanding.
What happened to Sino Biopharmaceutical Ltd’s price movement after its last earnings report?
Sino Biopharmaceutical Ltd reported an EPS of HK$0.049 in its last earnings report, missing expectations of HK$0.086. Following the earnings report the stock price went up 0.332%.
Which hedge fund is a major shareholder of Sino Biopharmaceutical Ltd?
Currently, no hedge funds are holding shares in HK:1177
---
Sino Biopharmaceutical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$5.31 (73.61% Upside)
HK$5.31 (73.61% Upside)
Insider Transactions
Bought Shares
Worth $2.9M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.36%
12-Months-Change
Fundamentals
Return on Equity
6.27%
Trailing 12-Months
Asset Growth
-2.68%
Trailing 12-Months
Company Description
Sino Biopharmaceutical Ltd
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
---
1177 Stock 12 Month Forecast
Average Price Target
HK$5.31
▲(73.61% Upside)
Technical Analysis
Sino Biopharmaceutical
―
GlaxoSmithKline
―
Bristol-Myers Squibb
―
AstraZeneca
―
Sanofi
―
Best Analysts Covering 1177
1 Year
---